2013
DOI: 10.3390/ijms14011310
|View full text |Cite
|
Sign up to set email alerts
|

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers

Abstract: Brain is one of the richest organs in lipid content. Phospholipids (glycerophospholipids and sphingolipids) are important building blocks of cell membranes, which provide an optimal environment for protein interactions, trafficking and function. Because of that, alterations in their cellular levels could lead to different pathogenic processes in the brain, such as in Alzheimer’s disease (AD), the most common type of dementia among older populations. There is increasing evidence that phospholipid changes occur … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
143
0
4

Year Published

2013
2013
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 181 publications
(153 citation statements)
references
References 66 publications
6
143
0
4
Order By: Relevance
“…Moreover, several studies have correlated the biochemical changes occurred in central nervous system with impaired brain function and its consequences in myocardium diseases (Black andGarbutt, 2002, Pereira et al, 2012). In both of these organs, phospholipids are very important biomolecules and their profile alterations have been related with many diseases of the brain and of the myocardium (Han, 2010, Kosicek M and Hecimovic S 2013, Salomon 2012. Therefore, we examined the effects of CUS on superoxide dismutase, catalase (CAT), glutathione reductase activities and glutathione oxidation in mice brain and myocardium.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, several studies have correlated the biochemical changes occurred in central nervous system with impaired brain function and its consequences in myocardium diseases (Black andGarbutt, 2002, Pereira et al, 2012). In both of these organs, phospholipids are very important biomolecules and their profile alterations have been related with many diseases of the brain and of the myocardium (Han, 2010, Kosicek M and Hecimovic S 2013, Salomon 2012. Therefore, we examined the effects of CUS on superoxide dismutase, catalase (CAT), glutathione reductase activities and glutathione oxidation in mice brain and myocardium.…”
Section: Discussionmentioning
confidence: 99%
“…Normal aging is accompanied by a gradual decrease and change in brain lipid composition ( 18 ), and in our CH population, there was normal GP turnover with homeostatic control of infl ammatory lipid levels in the SF and NP fractions. Under these conditions, processing of amyloid precursor protein and lipid-associated clearance of neurotoxic peptides are not hindered, PLA 2 activity is at a 'normal level," and neuroinfl ammation is controlled, resulting in slower neurodegeneration.…”
Section: Role Of Gp Metabolism In Clinical Groupsmentioning
confidence: 99%
“…27 Additionally, both of these lipids have been shown to act as biomarkers for Alzheimer's disease. 28,29 In the current work, the levels of hydration and the location of the water in three-dimensional space around the headgroup within a bilayer has been assessed on the atomic length scale. Importantly, the hydration of specific headgroup moieties has been further compared to previous investigations on the atomic scale hydration of both ceramide 30 and phosphatidylcholine (PC) headgroup in solution.…”
Section: Introductionmentioning
confidence: 99%